9-methyl-3-(5-methylazonan-1-yl)-8-(2-methyl-1,3-benzothiazol-6-yl)-9,10-dihydropyrido[1,2-a]azocin-6-one
C29H35N3OS — CID 123526991
Data last refreshed: (MolForge compound catalog, from PubChem)
About 9-methyl-3-(5-methylazonan-1-yl)-8-(2-methyl-1,3-benzothiazol-6-yl)-9,10-dihydropyrido[1,2-a]azocin-6-one
9-methyl-3-(5-methylazonan-1-yl)-8-(2-methyl-1,3-benzothiazol-6-yl)-9,10-dihydropyrido[1,2-a]azocin-6-one (PubChem CID 123526991) has the molecular formula C29H35N3OS and a molecular weight of 473.69 g/mol. Its IUPAC name is 9-methyl-3-(5-methylazonan-1-yl)-8-(2-methyl-1,3-benzothiazol-6-yl)-9,10-dihydropyrido[1,2-a]azocin-6-one.
Molecular Properties
| Compound Name | 9-methyl-3-(5-methylazonan-1-yl)-8-(2-methyl-1,3-benzothiazol-6-yl)-9,10-dihydropyrido[1,2-a]azocin-6-one |
|---|---|
| PubChem CID | 123526991 |
| Molecular Formula | C29H35N3OS |
| Molecular Weight | 473.69 g/mol |
| Exact Mass | 473.25 |
| IUPAC Name | 9-methyl-3-(5-methylazonan-1-yl)-8-(2-methyl-1,3-benzothiazol-6-yl)-9,10-dihydropyrido[1,2-a]azocin-6-one |
| SMILES | Cc1nc2ccc(C3=CC(=O)N4C=C(N5CCCCC(C)CCC5)C=CC4=CCC3C)cc2s1 |
| InChI | InChI=1S/C29H35N3OS/c1-20-7-4-5-15-31(16-6-8-20)25-13-12-24-11-9-21(2)26(18-29(33)32(24)19-25)23-10-14-27-28(17-23)34-22(3)30-27/h10-14,17-21H,4-9,15-16H2,1-3H3 |
| InChIKey | NELIVQFCYHIODK-UHFFFAOYSA-N |
| XLogP | 7.05 |
| TPSA | 36.44 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 473.69 |
| LogP ≤ 5 | 7.05 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123526991 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.